1. Alves L, Hülsmeyer V, Jaggy A, Fischer A, Leeb T, Drögemüller M. Polymorphisms in the
ABCB1 gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies. J Vet Intern Med. 2011; 25:484–489.
Article
2. Baars C, Leeb T, von Klopmann T, Tipold A, Potschka H. Allele-specific polymerase chain reaction diagnostic test for the functional
MDR1 polymorphism in dogs. Vet J. 2008; 177:394–397.
Article
3. Borst P, Schinkel AH. P-glycoprotein ABCB1: a major player in drug handling by mammals. J Clin Invest. 2013; 123:4131–4133.
4. Bugde P, Biswas R, Merien F, Lu J, Liu DX, Chen M, Zhou S, Li Y. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Expert Opin Ther Targets. 2017; 21:511–530.
Article
5. Callaghan R, Luk F, Bebawy M. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos. 2014; 42:623–631.
Article
6. Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016; 370:153–164.
Article
7. Fromm MF. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther. 2000; 38:69–74.
Article
8. Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E. Development of a PCR-based diagnostic test detecting a nt230(del4)
MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. J Vet Pharmacol Ther. 2005; 28:95–99.
Article
9. Gramer I, Kessler M, Geyer J. Determination of
MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma. Vet Comp Oncol. 2015; 13:363–372.
Article
10. Kawabata A, Momoi Y, Inoue-Murayama M, Iwasaki T. Canine mdr1 gene mutation in Japan. J Vet Med Sci. 2005; 67:1103–1107.
11. Klintzsch S, Meerkamp K, Döring B, Geyer J. Detection of the nt230[del4]
MDR1 mutation in dogs by a fluorogenic 5′ nuclease TaqMan allelic discrimination method. Vet J. 2010; 185:272–277.
Article
12. Lind DL, Fidel JL, Gay JM, Mealey KL. Evaluation of vincristine-associated myelosuppression in Border Collies. Am J Vet Res. 2013; 74:257–261.
Article
13. Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001; 11:727–733.
Article
14. Mealey KL, Fidel J. P-glycoprotein mediated drug interactions in animals and humans with cancer. J Vet Intern Med. 2015; 29:1–6.
Article
15. Mealey KL, Fidel J, Gay JM, Impellizeri JA, Clifford CA, Bergman PJ. ABCB1-1Δ polymorphism can predict hematologic toxicity in dogs treated with vincristine. J Vet Intern Med. 2008; 22:996–1000.
Article
16. Mizukami K, Chang HS, Yabuki A, Kawamichi T, Hossain MA, Rahman MM, Uddin MM, Yamato O. Rapid genotyping assays for the 4-base pair deletion of canine
MDR1/ABCB1 gene and low frequency of the mutant allele in Border Collie dogs. J Vet Diagn Invest. 2012; 24:127–134.
Article
17. Mizukami K, Yabuki A, Chang HS, Uddin MM, Rahman MM, Kushida K, Kohyama M, Yamato O. High frequency of a single nucleotide substitution (c.-6-180T>G) of the canine
MDR1/ABCB1 gene associated with phenobarbital-resistant idiopathic epilepsy in Border Collie dogs. Dis Markers. 2013; 35:669–672.
Article
18. Plumb DC. Plumb's Veterinary Drug Handbook. Stockholm: PharmaVet;2011.
19. Stiedl CP, Weber K. Fast and simple detection methods for the 4-base pair deletion of canine
MDR1/ABCB1 gene by PCR and isothermal amplification. J Vet Diagn Invest. 2017; 29:176–180.
Article
20. Takane H, Kobayashi D, Hirota T, Kigawa J, Terakawa N, Otsubo K, Ieiri I. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the
MDR1 (
ABCB1) gene. J Pharmacol Exp Ther. 2004; 311:1179–1187.
Article
21. Veterinary Co-operative Oncology Group (VCOG). Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncol. 2004; 2:195–213.